Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Lebovitz

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Current Therapy in Endocrinology and Metabolism|January 1, 1997
Insulin allergy and insulin resistanceH E Lebovitz
Drugs|January 1, 1992
Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitorsH E Lebovitz
Primary Care|June 1, 1988
Oral hypoglycemic agentsH E Lebovitz
Endocrinology and Metabolism Clinics of North America|October 6, 1997
alpha-Glucosidase inhibitorsH E Lebovitz
Clinical Chemistry|August 3, 1999
Type 2 diabetes: an overviewH E Lebovitz
The American Journal of Cardiology|September 29, 2001
Effect of the postprandial state on nontraditional risk factorsH E Lebovitz
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 20, 2001
Insulin resistance: definition and consequencesH E Lebovitz
Diabetes Care|April 6, 1999
Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetesH E Lebovitz
The American Journal of Medicine|November 30, 1983
Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitusH E Lebovitz
The American Journal of Medicine|September 18, 1987
Type II diabetes mellitus: a treatment dilemma. IntroductionH E Lebovitz
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Current Therapy in Endocrinology and Metabolism|January 1, 1997
Insulin allergy and insulin resistanceH E Lebovitz
Drugs|January 1, 1992
Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitorsH E Lebovitz
Primary Care|June 1, 1988
Oral hypoglycemic agentsH E Lebovitz
Endocrinology and Metabolism Clinics of North America|October 6, 1997
alpha-Glucosidase inhibitorsH E Lebovitz
Clinical Chemistry|August 3, 1999
Type 2 diabetes: an overviewH E Lebovitz
The American Journal of Cardiology|September 29, 2001
Effect of the postprandial state on nontraditional risk factorsH E Lebovitz
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 20, 2001
Insulin resistance: definition and consequencesH E Lebovitz
Diabetes Care|April 6, 1999
Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetesH E Lebovitz
The American Journal of Medicine|November 30, 1983
Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitusH E Lebovitz
The American Journal of Medicine|September 18, 1987
Type II diabetes mellitus: a treatment dilemma. IntroductionH E Lebovitz
Pageof 15